ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of prostate tumors and metastatic lymph nodes. By correlating the ICG fluorescence patterns with pathologically confirmed tumor and nodal status, it would be possible to use fluorescence navigation system in helping prostate biopsy and lymph node dissection in the future.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Third Affiliated Hospital, Sun Yat-Sen University

Criteria

Inclusion Criteria:

• Histologically confirmed prostate cancer;

• Able to accept total prostatectomy;

• Patient has given its informed consent.

Exclusion Criteria:

• Allergic to ICG or iodine;

• High-grade hepatic insufficiency

• refuse attending the study